|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,138.90 INR | -3.13% |
|
-2.20% | -2.62% |
| 27/02 | Mankind Pharma says tax penalty of 10.2 million rupees dropped | RE |
| 16/02 | Mankind Pharma says tax penalty of 4.6 million rupees dropped | RE |
| Capitalization | 88TCr 954.61Cr 834.43Cr 753.86Cr 721.15Cr 1.31TCr 1.36TCr 9.01TCr 3.57TCr 42TCr 3.58TCr 3.51TCr 1,52400Cr | P/E ratio 2026 * |
46.8x | P/E ratio 2027 * | 36.1x |
|---|---|---|---|---|---|
| Enterprise value | 94TCr 1.01TCr 885.48Cr 799.98Cr 765.27Cr 1.39TCr 1.45TCr 9.56TCr 3.79TCr 45TCr 3.8TCr 3.72TCr 1,61700Cr | EV / Sales 2026 * |
6.52x | EV / Sales 2027 * | 5.7x |
| Free-Float |
22.83% | Yield 2026 * |
0.19% | Yield 2027 * | 0.29% |
Last Transcript: Mankind Pharma Limited
| 1 day | -3.13% | ||
| 1 week | -2.20% | ||
| Current month | -4.84% | ||
| 1 month | +3.80% | ||
| 3 months | -1.83% | ||
| 6 months | -17.08% | ||
| Current year | -2.62% |
| 1 week | 2,108.3 | 2,256.8 | |
| 1 month | 2,012.3 | 2,284.9 | |
| Current year | 2,012.3 | 2,320.9 | |
| 1 year | 2,012.3 | 2,716.5 | |
| 3 years | 1,242 | 3,054.8 | |
| 5 years | 1,242 | 3,054.8 | |
| 10 years | 1,242 | 3,054.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sheetal Arora
CEO | Chief Executive Officer | 50 | 21/09/2007 |
Ashutosh Dhawan
DFI | Director of Finance/CFO | 57 | 03/03/2016 |
| Compliance Officer | 48 | 09/01/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 70 | 03/07/1991 | |
Rajeev Juneja
BRD | Director/Board Member | 60 | 22/12/1992 |
Sheetal Arora
BRD | Director/Board Member | 50 | 21/09/2007 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -3.13% | -2.20% | -2.83% | - | 954.61Cr | ||
| +0.80% | -0.53% | +21.09% | +201.18% | 88TCr | ||
| -0.21% | +0.47% | +48.34% | +56.91% | 58TCr | ||
| -2.52% | -4.53% | +3.74% | +42.79% | 39TCr | ||
| +0.79% | -6.01% | +4.87% | +20.81% | 32TCr | ||
| +0.11% | -0.83% | +19.89% | +34.57% | 30TCr | ||
| +0.43% | -1.54% | +25.96% | +62.12% | 29TCr | ||
| -0.26% | -0.16% | +22.25% | +8.08% | 29TCr | ||
| -0.43% | -0.90% | +16.74% | +58.82% | 20TCr | ||
| +0.42% | +0.74% | +30.11% | +81.76% | 18TCr | ||
| Average | -0.40% | -1.55% | +19.02% | +63.00% | 34.36TCr | |
| Weighted average by Cap. | -0.03% | -1.37% | +22.78% | +84.81% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 14TCr 155.32Cr 135.76Cr 122.65Cr 117.33Cr 213.41Cr 221.84Cr 1.47TCr 580.66Cr 6.86TCr 582.82Cr 570.51Cr 25TCr | 16TCr 172.8Cr 151.04Cr 136.46Cr 130.54Cr 237.43Cr 246.81Cr 1.63TCr 646.03Cr 7.64TCr 648.43Cr 634.73Cr 28TCr |
| Net income | 1.85TCr 20Cr 17Cr 16Cr 15Cr 28Cr 29Cr 188.85Cr 75Cr 884.59Cr 75Cr 74Cr 3.2TCr | 2.44TCr 26Cr 23Cr 21Cr 20Cr 36Cr 38Cr 248.39Cr 98Cr 1.16TCr 99Cr 97Cr 4.2TCr |
| Net Debt | 5.4TCr 58Cr 51Cr 46Cr 44Cr 80Cr 83Cr 550.97Cr 218.35Cr 2.58TCr 219.16Cr 214.53Cr 9.32TCr | 2.87TCr 31Cr 27Cr 24Cr 23Cr 43Cr 44Cr 292.37Cr 115.87Cr 1.37TCr 116.3Cr 113.84Cr 4.95TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/26/13 | 2,138.90 ₹ | -3.13% | 8,01,859 |
| 12/26/12 | 2,207.90 ₹ | -1.60% | 3,10,028 |
| 11/26/11 | 2,243.80 ₹ | +0.27% | 4,15,703 |
| 10/26/10 | 2,237.70 ₹ | +3.44% | 10,43,920 |
| 09/26/09 | 2,163.30 ₹ | -1.08% | 8,26,127 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- MANKIND Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
















